| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 16.430 | 48.779 | 70.589 | 57.358 | 563.652 | 665.611 | 611.615 | 700.697 |
| Total Income - EUR | - | - | 16.736 | 49.016 | 70.717 | 57.882 | 569.489 | 665.712 | 611.737 | 700.796 |
| Total Expenses - EUR | - | - | 18.799 | 49.846 | 67.420 | 55.521 | 423.027 | 612.644 | 553.365 | 634.748 |
| Gross Profit/Loss - EUR | - | - | -2.063 | -830 | 3.297 | 2.361 | 146.462 | 53.068 | 58.372 | 66.048 |
| Net Profit/Loss - EUR | - | - | -2.339 | -1.321 | 2.590 | 1.813 | 141.476 | 47.410 | 39.983 | 56.530 |
| Employees | - | - | 1 | 3 | 3 | 3 | 6 | 8 | 7 | 7 |
Check the financial reports for the company - Morphl R&D S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 1.181 | 735 | 308 | 0 | 498 | 363 | 226 | 90 |
| Current Assets | - | - | 972 | 1.938 | 2.434 | 16.011 | 499.352 | 459.995 | 512.241 | 570.738 |
| Inventories | - | - | 10 | 12 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 15 | 477 | 917 | 11.952 | 471.989 | 293.733 | 281.931 | 164.389 |
| Cash | - | - | 947 | 1.450 | 1.517 | 4.060 | 27.363 | 166.261 | 230.311 | 406.349 |
| Shareholders Funds | - | - | -2.295 | -3.573 | -680 | 1.145 | 142.595 | 190.448 | 229.853 | 285.099 |
| Social Capital | - | - | 44 | 43 | 276 | 271 | 265 | 266 | 265 | 263 |
| Debts | - | - | 4.448 | 6.247 | 3.422 | 14.866 | 357.254 | 269.910 | 282.614 | 285.730 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6210 - 6210" | |||||||||
| CAEN Financial Year |
6201
|
|||||||||
Comments - Morphl R&D S.r.l.